
Fluorescent antibody testing (FAT) is a rabies diagnostic method based on antigen detection in fresh or frozen brain tissue and is a method recommended by the World Health Organization (WHO) and the World Organization for Animal Health (OIE). Reflected light fluorescence microscopy is used to detect antigens.
The global market for Fluorescent Antibody Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Fluorescent antibody testing (FAT) is a rabies diagnostic method based on antigen detection in fresh or frozen brain tissue and is a method recommended by the World Health Organization (WHO) and the World Organization for Animal Health (OIE). Reflected light fluorescence microscopy is used to detect antigens.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fluorescent Antibody Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fluorescent Antibody Test by region & country, by Type, and by Application.
The Fluorescent Antibody Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorescent Antibody Test.
Market Segmentation
By Company
Quidel Corporation
BioTek Instruments
Thermo Fisher Scientific
Dewinter Optical
Leica Microsystems
PicoQuant GmbH
Carl Zeiss AG
Cole-Parmer Instrument Company
Esco Micro Pte
BR Technologies
Merck KGaA
OLYMPUS CORPORATION
labome
Segment by Type:
Direct Test
Indirect Test
Segment by Application
Healthcare Providers
Pharmacies
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fluorescent Antibody Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Fluorescent Antibody Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Fluorescent Antibody Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Fluorescent Antibody Test Product Introduction
1.2 Global Fluorescent Antibody Test Market Size Forecast
1.3 Fluorescent Antibody Test Market Trends & Drivers
1.3.1 Fluorescent Antibody Test Industry Trends
1.3.2 Fluorescent Antibody Test Market Drivers & Opportunity
1.3.3 Fluorescent Antibody Test Market Challenges
1.3.4 Fluorescent Antibody Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fluorescent Antibody Test Players Revenue Ranking (2023)
2.2 Global Fluorescent Antibody Test Revenue by Company (2019-2024)
2.3 Key Companies Fluorescent Antibody Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies Fluorescent Antibody Test Product Offered
2.5 Key Companies Time to Begin Mass Production of Fluorescent Antibody Test
2.6 Fluorescent Antibody Test Market Competitive Analysis
2.6.1 Fluorescent Antibody Test Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Fluorescent Antibody Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorescent Antibody Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Direct Test
3.1.2 Indirect Test
3.2 Global Fluorescent Antibody Test Sales Value by Type
3.2.1 Global Fluorescent Antibody Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fluorescent Antibody Test Sales Value, by Type (2019-2030)
3.2.3 Global Fluorescent Antibody Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Healthcare Providers
4.1.2 Pharmacies
4.1.3 Clinics
4.2 Global Fluorescent Antibody Test Sales Value by Application
4.2.1 Global Fluorescent Antibody Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fluorescent Antibody Test Sales Value, by Application (2019-2030)
4.2.3 Global Fluorescent Antibody Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Fluorescent Antibody Test Sales Value by Region
5.1.1 Global Fluorescent Antibody Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fluorescent Antibody Test Sales Value by Region (2019-2024)
5.1.3 Global Fluorescent Antibody Test Sales Value by Region (2025-2030)
5.1.4 Global Fluorescent Antibody Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Fluorescent Antibody Test Sales Value, 2019-2030
5.2.2 North America Fluorescent Antibody Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Fluorescent Antibody Test Sales Value, 2019-2030
5.3.2 Europe Fluorescent Antibody Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Fluorescent Antibody Test Sales Value, 2019-2030
5.4.2 Asia Pacific Fluorescent Antibody Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Fluorescent Antibody Test Sales Value, 2019-2030
5.5.2 South America Fluorescent Antibody Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Fluorescent Antibody Test Sales Value, 2019-2030
5.6.2 Middle East & Africa Fluorescent Antibody Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fluorescent Antibody Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fluorescent Antibody Test Sales Value
6.3 United States
6.3.1 United States Fluorescent Antibody Test Sales Value, 2019-2030
6.3.2 United States Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fluorescent Antibody Test Sales Value, 2019-2030
6.4.2 Europe Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fluorescent Antibody Test Sales Value, 2019-2030
6.5.2 China Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fluorescent Antibody Test Sales Value, 2019-2030
6.6.2 Japan Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fluorescent Antibody Test Sales Value, 2019-2030
6.7.2 South Korea Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fluorescent Antibody Test Sales Value, 2019-2030
6.8.2 Southeast Asia Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fluorescent Antibody Test Sales Value, 2019-2030
6.9.2 India Fluorescent Antibody Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fluorescent Antibody Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Quidel Corporation
7.1.1 Quidel Corporation Profile
7.1.2 Quidel Corporation Main Business
7.1.3 Quidel Corporation Fluorescent Antibody Test Products, Services and Solutions
7.1.4 Quidel Corporation Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.1.5 Quidel Corporation Recent Developments
7.2 BioTek Instruments
7.2.1 BioTek Instruments Profile
7.2.2 BioTek Instruments Main Business
7.2.3 BioTek Instruments Fluorescent Antibody Test Products, Services and Solutions
7.2.4 BioTek Instruments Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.2.5 BioTek Instruments Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Fluorescent Antibody Test Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.3.5 Dewinter Optical Recent Developments
7.4 Dewinter Optical
7.4.1 Dewinter Optical Profile
7.4.2 Dewinter Optical Main Business
7.4.3 Dewinter Optical Fluorescent Antibody Test Products, Services and Solutions
7.4.4 Dewinter Optical Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.4.5 Dewinter Optical Recent Developments
7.5 Leica Microsystems
7.5.1 Leica Microsystems Profile
7.5.2 Leica Microsystems Main Business
7.5.3 Leica Microsystems Fluorescent Antibody Test Products, Services and Solutions
7.5.4 Leica Microsystems Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.5.5 Leica Microsystems Recent Developments
7.6 PicoQuant GmbH
7.6.1 PicoQuant GmbH Profile
7.6.2 PicoQuant GmbH Main Business
7.6.3 PicoQuant GmbH Fluorescent Antibody Test Products, Services and Solutions
7.6.4 PicoQuant GmbH Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.6.5 PicoQuant GmbH Recent Developments
7.7 Carl Zeiss AG
7.7.1 Carl Zeiss AG Profile
7.7.2 Carl Zeiss AG Main Business
7.7.3 Carl Zeiss AG Fluorescent Antibody Test Products, Services and Solutions
7.7.4 Carl Zeiss AG Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.7.5 Carl Zeiss AG Recent Developments
7.8 Cole-Parmer Instrument Company
7.8.1 Cole-Parmer Instrument Company Profile
7.8.2 Cole-Parmer Instrument Company Main Business
7.8.3 Cole-Parmer Instrument Company Fluorescent Antibody Test Products, Services and Solutions
7.8.4 Cole-Parmer Instrument Company Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.8.5 Cole-Parmer Instrument Company Recent Developments
7.9 Esco Micro Pte
7.9.1 Esco Micro Pte Profile
7.9.2 Esco Micro Pte Main Business
7.9.3 Esco Micro Pte Fluorescent Antibody Test Products, Services and Solutions
7.9.4 Esco Micro Pte Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.9.5 Esco Micro Pte Recent Developments
7.10 BR Technologies
7.10.1 BR Technologies Profile
7.10.2 BR Technologies Main Business
7.10.3 BR Technologies Fluorescent Antibody Test Products, Services and Solutions
7.10.4 BR Technologies Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.10.5 BR Technologies Recent Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Profile
7.11.2 Merck KGaA Main Business
7.11.3 Merck KGaA Fluorescent Antibody Test Products, Services and Solutions
7.11.4 Merck KGaA Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.11.5 Merck KGaA Recent Developments
7.12 OLYMPUS CORPORATION
7.12.1 OLYMPUS CORPORATION Profile
7.12.2 OLYMPUS CORPORATION Main Business
7.12.3 OLYMPUS CORPORATION Fluorescent Antibody Test Products, Services and Solutions
7.12.4 OLYMPUS CORPORATION Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.12.5 OLYMPUS CORPORATION Recent Developments
7.13 labome
7.13.1 labome Profile
7.13.2 labome Main Business
7.13.3 labome Fluorescent Antibody Test Products, Services and Solutions
7.13.4 labome Fluorescent Antibody Test Revenue (US$ Million) & (2019-2024)
7.13.5 labome Recent Developments
8 Industry Chain Analysis
8.1 Fluorescent Antibody Test Industrial Chain
8.2 Fluorescent Antibody Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fluorescent Antibody Test Sales Model
8.5.2 Sales Channel
8.5.3 Fluorescent Antibody Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Quidel Corporation
BioTek Instruments
Thermo Fisher Scientific
Dewinter Optical
Leica Microsystems
PicoQuant GmbH
Carl Zeiss AG
Cole-Parmer Instrument Company
Esco Micro Pte
BR Technologies
Merck KGaA
OLYMPUS CORPORATION
labome
Ìý
Ìý
*If Applicable.
